{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:11:44Z","timestamp":1794028304789,"version":"4.8.0"},"reference-count":57,"publisher":"American Society of Hematology","issue":"13","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,7,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>von Willebrand disease (VWD) type 2 is caused by qualitative abnormalities of von Willebrand factor (VWF). This study aimed to determine the genotypic and phenotypic characterizations of a large VWD type 2 cohort from Milan. We included 321 patients (54% female) within 148 unrelated families from 1995 to 2021. Patients were fully characterized using laboratory phenotypic tests, and the genotypic diagnosis was confirmed by target genetic analysis using Sanger sequencing. Patients were diagnosed with type 2A (n = 98; 48 families), 2B (n = 85; 38 families), 2M (n = 112; 50 families), or 2N (n = 26; 12 families). Eighty-two unique VWF variants, including 8 novel variants, were found. The potential pathogenic effect of novel variants was assessed by in silico analysis. Most patients were heterozygous for a single variant (n = 259; 81%), whereas 37 cases (11%) had 2 variants (4 homozygous, 9 in trans, and 24 in cis). Twenty-five patients (8%) had \u22653 variants, mainly as a result of gene conversions. Among the 82 distinct variants identified, 5 different types, including missense (n = 64), gene conversion (n = 10), synonymous (n = 1), deletion (n = 4), and splice (n = 3), were observed. The results from this large cohort showed that VWD type 2 is invariably due to variants that do not prevent the synthesis of the protein, and a vast majority of patients (88%) had missense variants. Given the complexity of type 2 diagnosis and the necessity of performing several phenotypic tests, genetic analysis for patients suspected of having type 2 is beneficial to establish the correct diagnosis.<\/jats:p>","DOI":"10.1182\/bloodadvances.2022007216","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T19:32:50Z","timestamp":1650655970000},"page":"4031-4040","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":34,"title":["Phenotypic and genetic characterizations of the Milan cohort of von Willebrand disease type 2"],"prefix":"10.1182","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6630-7879","authenticated-orcid":false,"given":"Omid","family":"Seidizadeh","sequence":"first","affiliation":[{"name":"1Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; and"},{"name":"2Universit\u00e0 degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciano","family":"Baronciani","sequence":"additional","affiliation":[{"name":"1Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0778-2271","authenticated-orcid":false,"given":"Maria Teresa","family":"Pagliari","sequence":"additional","affiliation":[{"name":"1Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0267-3773","authenticated-orcid":false,"given":"Giovanna","family":"Cozzi","sequence":"additional","affiliation":[{"name":"1Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4180-6011","authenticated-orcid":false,"given":"Paola","family":"Colpani","sequence":"additional","affiliation":[{"name":"1Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cairo","sequence":"additional","affiliation":[{"name":"1Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8456-7519","authenticated-orcid":false,"given":"Simona Maria","family":"Siboni","sequence":"additional","affiliation":[{"name":"1Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1818-3872","authenticated-orcid":false,"given":"Eugenia","family":"Biguzzi","sequence":"additional","affiliation":[{"name":"1Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7423-9864","authenticated-orcid":false,"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[{"name":"1Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Milan, Italy; and"},{"name":"2Universit\u00e0 degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2022,7,11]]},"reference":[{"issue":"6","key":"2022072620154199400_B1","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0022-3476(05)80384-1","article-title":"Prevalence of von Willebrand disease in children: a multiethnic study","volume":"123","author":"Werner","year":"1993","journal-title":"J Pediatr."},{"issue":"2","key":"2022072620154199400_B2","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1182\/blood.V69.2.454.454","article-title":"Epidemiological investigation of the prevalence of von Willebrand\u2019s disease","volume":"69","author":"Rodeghiero","year":"1987","journal-title":"Blood."},{"issue":"21","key":"2022072620154199400_B3","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1056\/NEJMra1601561","article-title":"Von Willebrand\u2019s disease","volume":"375","author":"Leebeek","year":"2016","journal-title":"N Engl J Med."},{"issue":"10","key":"2022072620154199400_B4","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1111\/j.1538-7836.2006.02146.x","article-title":"Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor","volume":"4","author":"Sadler","year":"2006","journal-title":"J Thromb Haemost."},{"key":"2022072620154199400_B5","first-page":"s3","article-title":"Role of von Willebrand factor in the haemostasis","volume":"9","author":"Peyvandi","year":"2011","journal-title":"Blood Transfus."},{"issue":"1","key":"2022072620154199400_B6","first-page":"17","article-title":"von Willebrand factor: form for function","volume":"40","author":"Yee","year":"2014","journal-title":"Semin Thromb Hemost."},{"issue":"9","key":"2022072620154199400_B7","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1182\/blood-2014-05-378638","article-title":"von Willebrand factor, Jedi knight of the bloodstream","volume":"124","author":"Springer","year":"2014","journal-title":"Blood."},{"issue":"4","key":"2022072620154199400_B8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/1076029606293422","article-title":"Classification and characterization of hereditary types 2A, 2B, 2C, 2D, 2E, 2M, 2N, and 2U (unclassifiable) von Willebrand disease","volume":"12","author":"Michiels","year":"2006","journal-title":"Clin Appl Thromb Hemost."},{"issue":"23","key":"2022072620154199400_B9","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2009-07-226324","article-title":"A cluster of mutations in the D3 domain of von Willebrand factor correlates with a distinct subgroup of von Willebrand disease: type 2A\/IIE","volume":"115","author":"Schneppenheim","year":"2010","journal-title":"Blood."},{"issue":"3","key":"2022072620154199400_B10","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1182\/blood-2008-04-152280","article-title":"Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients","volume":"113","author":"Federici","year":"2009","journal-title":"Blood."},{"issue":"3","key":"2022072620154199400_B11","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood.V68.3.668.668","article-title":"von Willebrand\u2019s disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma","volume":"68","author":"Holmberg","year":"1986","journal-title":"Blood."},{"issue":"1","key":"2022072620154199400_B12","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers","volume":"68","author":"Weiss","year":"1986","journal-title":"Blood."},{"issue":"6","key":"2022072620154199400_B13","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1111\/j.1538-7836.2010.03869.x","article-title":"Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD","volume":"8","author":"Flood","year":"2010","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022072620154199400_B14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/jth.15247","article-title":"von Willebrand disease type 2N: an update","volume":"19","author":"Seidizadeh","year":"2021","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022072620154199400_B15","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1055\/s-0039-3402430","article-title":"Genetic background of von Willebrand disease: history, current state, and future perspectives","volume":"46","author":"Zolkova","year":"2020","journal-title":"Semin Thromb Hemost."},{"issue":"1","key":"2022072620154199400_B16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jth.15116","article-title":"Increasing levels of von Willebrand factor and factor VIII with age in patients affected by von Willebrand disease","volume":"19","author":"Biguzzi","year":"2021","journal-title":"J Thromb Haemost."},{"key":"2022072620154199400_B17","author":"Human Genome Variation Society"},{"key":"2022072620154199400_B18","author":"Cooper"},{"key":"2022072620154199400_B19","author":"Leiden Open Variation Database"},{"issue":"6","key":"2022072620154199400_B20","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1365-2516.2006.01393.x","article-title":"The 80th anniversary of von Willebrand\u2019s disease: history, management and research","volume":"12","author":"Federici","year":"2006","journal-title":"Haemophilia."},{"key":"2022072620154199400_B21","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.thromres.2019.07.010","article-title":"How we make an accurate diagnosis of von Willebrand disease","volume":"196","author":"Baronciani","year":"2020","journal-title":"Thromb Res."},{"issue":"2","key":"2022072620154199400_B22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/hae.13175","article-title":"Molecular diagnosis of von Willebrand disease","volume":"23","author":"Baronciani","year":"2017","journal-title":"Haemophilia."},{"issue":"3","key":"2022072620154199400_B23","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/jth.13243","article-title":"Developments in the diagnostic procedures for von Willebrand disease","volume":"14","author":"De Jong","year":"2016","journal-title":"J Thromb Haemost."},{"issue":"13","key":"2022072620154199400_B24","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1182\/blood-2014-08-528398","article-title":"Diagnostic approach to von Willebrand disease","volume":"125","author":"Ng","year":"2015","journal-title":"Blood."},{"issue":"1","key":"2022072620154199400_B25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/bloodadvances.2020003265","article-title":"ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease","volume":"5","author":"James","year":"2021","journal-title":"Blood Adv."},{"issue":"3","key":"2022072620154199400_B26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2010.03.003","article-title":"The genetic basis of von Willebrand disease","volume":"24","author":"Goodeve","year":"2010","journal-title":"Blood Rev."},{"issue":"11","key":"2022072620154199400_B27","doi-asserted-by":"crossref","first-page":"e3038","DOI":"10.1097\/MD.0000000000003038","article-title":"A laboratory phenotype\/genotype correlation of 1167 French patients from 670 families with von Willebrand disease: a new epidemiologic picture","volume":"95","author":"Veyradier","year":"2016","journal-title":"Medicine (Baltimore)."},{"issue":"12","key":"2022072620154199400_B28","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.3324\/haematol.2017.168765","article-title":"Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients","volume":"102","author":"Borr\u00e0s","year":"2017","journal-title":"Haematologica."},{"issue":"21","key":"2022072620154199400_B29","doi-asserted-by":"crossref","first-page":"XXX","DOI":"10.1182\/blood.V124.21.472.472","article-title":"Spectrum of type 2 von Willebrand disease in the Zimmerman program [abstract]","volume":"124","author":"Flood","year":"2014","journal-title":"Blood."},{"issue":"1","key":"2022072620154199400_B30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/hae.13366","article-title":"Type 2N von Willebrand disease: characterization and diagnostic difficulties","volume":"24","author":"Casonato","year":"2018","journal-title":"Haemophilia."},{"issue":"5","key":"2022072620154199400_B31","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1538-7836.2008.02941.x","article-title":"Prevalence of type 2b \u2018Malm\u00f6\/New York\u2019 von Willebrand disease in Italy: the role of von Willebrand factor gene conversion","volume":"6","author":"Baronciani","year":"2008","journal-title":"J Thromb Haemost."},{"issue":"14","key":"2022072620154199400_B32","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1182\/blood-2014-11-610824","article-title":"Crucial role for the VWF A1 domain in binding to type IV collagen","volume":"125","author":"Flood","year":"2015","journal-title":"Blood."},{"issue":"7","key":"2022072620154199400_B33","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1538-7836.2012.04746.x","article-title":"Critical von Willebrand factor A1 domain residues influence type VI collagen binding","volume":"10","author":"Flood","year":"2012","journal-title":"J Thromb Haemost."},{"issue":"7","key":"2022072620154199400_B34","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/jth.12280","article-title":"A synonymous (c.3390C&gt;T) or a splice-site (c.3380-2A&gt;G) mutation causes exon\u00a026 skipping in four patients with von Willebrand disease (2A\/IIE)","volume":"11","author":"Pagliari","year":"2013","journal-title":"J Thromb Haemost."},{"issue":"6","key":"2022072620154199400_B35","doi-asserted-by":"crossref","first-page":"e502","DOI":"10.1111\/hae.13084","article-title":"von Willebrand disease type 1 mutation p.Arg1379Cys and the variant p.Ala1377Val synergistically determine a 2M phenotype in four Italian patients","volume":"22","author":"Pagliari","year":"2016","journal-title":"Haemophilia."},{"issue":"7","key":"2022072620154199400_B36","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/j.1538-7836.2009.03457.x","article-title":"Type 2A (IIH) von Willebrand disease is due to mutations that affect von Willebrand factor multimerization","volume":"7","author":"Baronciani","year":"2009","journal-title":"J Thromb Haemost."},{"issue":"1","key":"2022072620154199400_B37","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3324\/haematol.2009.012336","article-title":"Premature termination codon mutations in the von Willebrand factor gene are associated with allele-specific and position-dependent mRNA decay","volume":"95","author":"Plat\u00e8","year":"2010","journal-title":"Haematologica."},{"issue":"1","key":"2022072620154199400_B38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/jth.15129","article-title":"Laboratory variability in the diagnosis of type 2 VWD variants","volume":"19","author":"DiGiandomenico","year":"2021","journal-title":"J Thromb Haemost."},{"issue":"4","key":"2022072620154199400_B39","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1182\/blood.V97.4.952","article-title":"The arginine-552-cysteine (R1315C) mutation within the A1 loop of von Willebrand factor induces an abnormal folding with a loss of function resulting in type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor","volume":"97","author":"Ribba","year":"2001","journal-title":"Blood."},{"issue":"1","key":"2022072620154199400_B40","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)","volume":"109","author":"Goodeve","year":"2007","journal-title":"Blood."},{"issue":"9","key":"2022072620154199400_B41","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/j.1538-7836.2007.02666.x","article-title":"Challenges in defining type 2M von Willebrand disease: results from a Canadian cohort study","volume":"5","author":"James","year":"2007","journal-title":"J Thromb Haemost."},{"issue":"5","key":"2022072620154199400_B42","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0031-1281031","article-title":"The International Society on Thrombosis and Haematosis von Willebrand Disease Database: an update","volume":"37","author":"Hampshire","year":"2011","journal-title":"Semin Thromb Hemost."},{"issue":"5","key":"2022072620154199400_B43","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/j.1538-7836.2012.04702.x","article-title":"Reduced von Willebrand factor secretion is associated with loss of Weibel-Palade body formation","volume":"10","author":"Castaman","year":"2012","journal-title":"J Thromb Haemost."},{"issue":"2","key":"2022072620154199400_B44","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/hae.13929","article-title":"Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand disease","volume":"26","author":"Stufano","year":"2020","journal-title":"Haemophilia."},{"issue":"2","key":"2022072620154199400_B45","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1111\/hae.13156","article-title":"VWF collagen (types III and VI)-binding defects in a cohort of type 2M VWD patients - a strategy for improvement of a challenging diagnosis","volume":"23","author":"Fidalgo","year":"2017","journal-title":"Haemophilia."},{"issue":"1","key":"2022072620154199400_B46","first-page":"17","article-title":"Genotype-phenotype correlation in a cohort of Portuguese patients comprising the entire spectrum of VWD types: impact of NGS","volume":"116","author":"Fidalgo","year":"2016","journal-title":"Thromb Haemost."},{"issue":"2-3","key":"2022072620154199400_B47","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000214855","article-title":"Dominant von Willebrand disease type 2M and 2U are variable expressions of one distinct disease entity caused by loss-of-function mutations in the A1 domain of the von Willebrand factor gene","volume":"121","author":"Gadisseur","year":"2009","journal-title":"Acta Haematol."},{"issue":"2-3","key":"2022072620154199400_B48","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000214853","article-title":"Laboratory diagnosis of von Willebrand disease type 1\/2E (2A subtype IIE), type 1 Vicenza and mild type 1 caused by mutations in the D3, D4, B1-B3 and C1-C2 domains of the von Willebrand factor gene. Role of von Willebrand factor multimers and the von Willebrand factor propeptide\/antigen ratio","volume":"121","author":"Gadisseur","year":"2009","journal-title":"Acta Haematol."},{"issue":"4","key":"2022072620154199400_B49","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1046\/j.1365-2141.2000.01944.x","article-title":"Autosomal dominant type 1 von willebrand disease due to G3639T mutation (C1130F) in exon 26 of von Willebrand factor gene: description of five Italian families and evidence for a founder effect","volume":"108","author":"Castaman","year":"2000","journal-title":"Br J Haematol."},{"key":"2022072620154199400_B50","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.thromres.2016.08.009","article-title":"Mutations in the D\u2019D3 region of VWF traditionally associated with type 1 VWD lead to quantitative and qualitative deficiencies of VWF","volume":"145","author":"White-Adams","year":"2016","journal-title":"Thromb Res."},{"issue":"1","key":"2022072620154199400_B51","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1182\/blood-2006-05-021105","article-title":"The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study","volume":"109","author":"James","year":"2007","journal-title":"Blood."},{"issue":"4","key":"2022072620154199400_B52","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1111\/hae.13532","article-title":"Differential diagnosis between type 2A and 2B von Willebrand disease in a child with a previously undescribed de novo mutation","volume":"24","author":"Pagliari","year":"2018","journal-title":"Haemophilia."},{"issue":"4","key":"2022072620154199400_B53","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1160\/TH12-02-0089","article-title":"Mutation distribution in the von Willebrand factor gene related to the different von Willebrand disease (VWD) types in a cohort of VWD patients","volume":"108","author":"Yadegari","year":"2012","journal-title":"Thromb Haemost."},{"issue":"1","key":"2022072620154199400_B54","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1538-7836.2009.03482.x","article-title":"Genetic testing for von Willebrand disease: the case against","volume":"8","author":"Favaloro","year":"2010","journal-title":"J Thromb Haemost."},{"issue":"5","key":"2022072620154199400_B55","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-0031-1281037","article-title":"Management of inherited von Willebrand disease in Italy: results from the retrospective study on 1234 patients","volume":"37","author":"Federici","year":"2011","journal-title":"Semin Thromb Hemost."},{"issue":"299","key":"2022072620154199400_B56","first-page":"2","article-title":"Determination of two rapid von Willebrand factor (VWF) activity assays VWF: Gpibm and VWF: Gpibr in well defined von Willebrand disease patients using a complete set of classical and sensitive VWF assays","volume":"6","author":"Michiels","year":"2019","journal-title":"J Hematol Thrombo Dis."},{"issue":"3","key":"2022072620154199400_B57","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/ajh.20470","article-title":"von Willebrand disease R1374C: type 2A or 2M? A challenge to the revised classification. High frequency in the northwest of Spain (Galicia)","volume":"80","author":"Penas","year":"2005","journal-title":"Am J Hematol."}],"updated-by":[{"DOI":"10.1182\/bloodadvances.2022008774","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000}}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/13\/4031\/1910760\/advancesadv2022007216.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/6\/13\/4031\/1910760\/advancesadv2022007216.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T20:16:46Z","timestamp":1658866606000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/6\/13\/4031\/485042\/Phenotypic-and-genetic-characterizations-of-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,11]]},"references-count":57,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2022,7,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2022007216","relation":{"erratum":[{"id-type":"doi","id":"10.1182\/bloodadvances.2022008774","asserted-by":"object"}]},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,11]]}}}